Athanor Capital, LP Vaxcyte, Inc. Transaction History

Athanor Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$18.66 - $29.16 $199,195 - $311,283	-10,675 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$26.57 - $51.74 $75,485 - $146,993	-2,841 Reduced 21.02%	10,675 $284,000
Q3 2020 Nov 16, 2020	BUY	$26.5 - $55.4 $358,174 - $748,786	13,516 New	13,516 $667,000

350

132M

577K

310K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.98B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.